49 CFR 40, Subpart F - Drug Testing Laboratories
- § 40.81 — What laboratories may be used for DOT drug testing?
- § 40.83 — How do laboratories process incoming specimens?
- § 40.85 — What drugs do laboratories test for?
- § 40.87 — What are the cutoff concentrations for drug tests?
- § 40.89 — What is validity testing, and are laboratories required to conduct it?
- § 40.91 — What validity tests must laboratories conduct on primary specimens?
- § 40.93 — What criteria do laboratories use to establish that a specimen is dilute or substituted?
- § 40.95 — What are the adulterant cutoff concentrations for initial and confirmation tests?
- § 40.96 — What criteria do laboratories use to establish that a specimen is invalid?
- § 40.97 — What do laboratories report and how do they report it?
- § 40.99 — How long does the laboratory retain specimens after testing?
- § 40.101 — What relationship may a laboratory have with an MRO?
- § 40.103 — What are the requirements for submitting blind specimens to a laboratory?
- § 40.105 — What happens if the laboratory reports a result different from that expected for a blind specimen?
- § 40.107 — Who may inspect laboratories?
- § 40.109 — What documentation must the laboratory keep, and for how long?
- § 40.111 — When and how must a laboratory disclose statistical summaries and other information it maintains?
- § 40.113 — Where is other information concerning laboratories found in this regulation?
Title 49 published on 2012-10-01
The following are only the Rules published in the Federal Register after the published date of Title 49.
For a complete list of all Rules, Proposed Rules, and Notices view the Rulemaking tab.
This is a list of United States Code sections, Statutes at Large, Public Laws, and Presidential Documents, which provide rulemaking authority for this CFR Part.
This list is taken from the Parallel Table of Authorities and Rules provided by GPO [Government Printing Office].
It is not guaranteed to be accurate or up-to-date, though we do refresh the database weekly. More limitations on accuracy are described at the GPO site.
§ 102 - Department of Transportation
§ 301 - Leadership, consultation, and cooperation
§ 322 - General powers
§ 5331 - Alcohol and controlled substances testing
§ 20140 - Alcohol and controlled substances testing
§ 31306 - Alcohol and controlled substances testing
§ 45101 - Definition
§ 45102 - Alcohol and controlled substances testing programs
§ 45103 - Prohibited service
§ 45104 - Testing and laboratory requirements
§ 45105 - Rehabilitation
§ 45106 - Relationship to other laws, regulations, standards, and orders
§ 45107 - Transportation Security Administration
§ 1618a
Title 49 published on 2012-10-01
The following are ALL rules, proposed rules, and notices (chronologically) published in the Federal Register relating to 49 CFR 40 after this date.
GPO FDSys XML | Text type regulations.gov FR Doc. 2012-24337 RIN 2105-AE14 Docket No. DOT-OST-2010-0026 DEPARTMENT OF TRANSPORTATION, Office of the Secretary Final rule. The rule is effective October 3, 2012. 49 CFR Part 40 This rule adopts as final, without change, a May 4, 2012, interim final rule (IFR) which no longer requires laboratories and Medical Review Officers (MRO) to consult with one another regarding the testing for the presence of morphine when the laboratory confirms the presence of 6-acetylmorphine (6-AM). Also, laboratories and MROs will no longer need to report 6-AM results to the Office of Drug and Alcohol Policy and Compliance (ODAPC). This rule also responds to comments on the IFR.